Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW, Dautzenberg FM (2003). „International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands”. Pharmacol. Rev. 55 (1): 21—6. PMID12615952. doi:10.1124/pr.55.1.3.
Polymeropoulos MH, Torres R, Yanovski JA, Chandrasekharappa SC, Ledbetter DH (1995). „The human corticotropin-releasing factor receptor (CRHR) gene maps to chromosome 17q12-q22”. Genomics. 28 (1): 123—4. PMID7590738. doi:10.1006/geno.1995.1118.
Nie Z, Schweitzer P, Roberts AJ, Madamba SG, Moore SD, Siggins GR (2004). „Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors”. Science (journal). 303 (5663): 1512—4. PMID15001778. doi:10.1126/science.1092550.
Tantisira KG, Lake S, Silverman ES, Palmer LJ, Lazarus R, Silverman EK, Liggett SB, Gelfand EW, Rosenwasser LJ, Richter B, Israel E, Wechsler M, Gabriel S, Altshuler D, Lander E, Drazen J, Weiss ST (2004). „Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids”. Hum. Mol. Genet. 13 (13): 1353—9. PMID15128701. doi:10.1093/hmg/ddh149.
Kehne JH (2007). „The CRF1 receptor, a novel target for the treatment of depression, anxiety, and stress-related disorders”. CNS Neurol Disord Drug Targets. 6 (3): 163—82. PMID17511614. doi:10.2174/187152707780619344.
Ising M, Holsboer F (2007). „CRH-sub-1 receptor antagonists for the treatment of depression and anxiety”. Exp Clin Psychopharmacol. 15 (6): 519—28. PMID18179304. doi:10.1037/1064-1297.15.6.519.
Grammatopoulos, D K; Dai Y; et al. (1999). „A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes”. Mol. Endocrinol. UNITED STATES. 13 (12): 2189—202. ISSN0888-8809. PMID10598591. doi:10.1210/me.13.12.2189.
Donaldson, C J; Sutton S W; et al. (1996). „Cloning and characterization of human urocortin”. Endocrinology. UNITED STATES. 137 (5): 2167—70. ISSN0013-7227. PMID8612563. doi:10.1210/en.137.5.2167.
nih.gov
ncbi.nlm.nih.gov
Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW, Dautzenberg FM (2003). „International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands”. Pharmacol. Rev. 55 (1): 21—6. PMID12615952. doi:10.1124/pr.55.1.3.
Polymeropoulos MH, Torres R, Yanovski JA, Chandrasekharappa SC, Ledbetter DH (1995). „The human corticotropin-releasing factor receptor (CRHR) gene maps to chromosome 17q12-q22”. Genomics. 28 (1): 123—4. PMID7590738. doi:10.1006/geno.1995.1118.
Nie Z, Schweitzer P, Roberts AJ, Madamba SG, Moore SD, Siggins GR (2004). „Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors”. Science (journal). 303 (5663): 1512—4. PMID15001778. doi:10.1126/science.1092550.
Tantisira KG, Lake S, Silverman ES, Palmer LJ, Lazarus R, Silverman EK, Liggett SB, Gelfand EW, Rosenwasser LJ, Richter B, Israel E, Wechsler M, Gabriel S, Altshuler D, Lander E, Drazen J, Weiss ST (2004). „Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids”. Hum. Mol. Genet. 13 (13): 1353—9. PMID15128701. doi:10.1093/hmg/ddh149.
Kehne JH (2007). „The CRF1 receptor, a novel target for the treatment of depression, anxiety, and stress-related disorders”. CNS Neurol Disord Drug Targets. 6 (3): 163—82. PMID17511614. doi:10.2174/187152707780619344.
Ising M, Holsboer F (2007). „CRH-sub-1 receptor antagonists for the treatment of depression and anxiety”. Exp Clin Psychopharmacol. 15 (6): 519—28. PMID18179304. doi:10.1037/1064-1297.15.6.519.
Grammatopoulos, D K; Dai Y; et al. (1999). „A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes”. Mol. Endocrinol. UNITED STATES. 13 (12): 2189—202. ISSN0888-8809. PMID10598591. doi:10.1210/me.13.12.2189.
Donaldson, C J; Sutton S W; et al. (1996). „Cloning and characterization of human urocortin”. Endocrinology. UNITED STATES. 137 (5): 2167—70. ISSN0013-7227. PMID8612563. doi:10.1210/en.137.5.2167.
worldcat.org
Grammatopoulos, D K; Dai Y; et al. (1999). „A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes”. Mol. Endocrinol. UNITED STATES. 13 (12): 2189—202. ISSN0888-8809. PMID10598591. doi:10.1210/me.13.12.2189.
Donaldson, C J; Sutton S W; et al. (1996). „Cloning and characterization of human urocortin”. Endocrinology. UNITED STATES. 137 (5): 2167—70. ISSN0013-7227. PMID8612563. doi:10.1210/en.137.5.2167.